NHS Framework Agreement - North of England - Tranche B
Details
- Buyer
- NHS England
- Supplier(s)
30 suppliers
- AVENTIS PHARMA LIMITED
- Astellas Pharma LTD.
- Bayer Public Limited Company
- Biogen Idec Ltd
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Daiichi Sankyo UK Ltd
- Eli Lilly and Company Ltd
- Esteve Pharmaceuticals Ltd
- Ferring Pharmaceutical
- GEDEON RICHTER (UK) LIMITED
- GENZYME THERAPEUTICS LIMITED
- Gilead Sciences Ltd, 280 High Holborn
- Ipsen Ltd
- Janssen Cilag Ltd
- LEOPHARMA LIMITED
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Mercury Pharmaceuticals Ltd
- Napp Pharmaceuticals
- Novartis Pharmaceutical UK Ltd
- Novo Nordisk Ltd
- OEHRINGER INGELHEIM LIMITED
- Pfizer Liimted
- Pharmasure Ltd
- Roche Products Ltd
- ROVI BIOTECH LIMITED
- Sandoz
- Takeda UK Limited
- Teva UK Ltd
- UCB Pharma Ltd
- Value
- GBP 521,100,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 19 April 2018
- Source
- ContractsFinder
Tender description
A framework is awarded for the supply of proprietary pharmaceuticals to participating Authorities in the NHS Region: North of England. The period of the resulting framework is 01 March 2018 - 29 February 2020, with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. The advertised awarding value of £521.1 million is the maximum value over the full potential 4 year period. The initial 2 year period of 1 March 2018 - 29 February 2020 therefore carries an awarding value of £260.55 million (£130.275 million per annum).
Timeline
- Completed: Award date8 January 2018
- Completed: Award published19 April 2018Current notice
- Completed: Contract expiry date29 February 2020
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework Agreement - North of England - Tranche B.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 461£2.1bn
- 372£250.0m
- 362£15.0bn
- 294£2.8bn
- 267£19.9bn
- 263£902.6m
- 250£511.2m
- 203£1.0bn
- 142£900.0m
- 122£59.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
